Epigenetic depletion of RNF144A has been detected in numerous human cancers, including glioblastoma (74), breast cancer (75), and bladder cancer (40), indicating that RNF144A may act as a tumor suppressor. This evidence concerns the gene RNF144A and urinary bladder carcinoma.